BioNexus Gene Lab Operating Expenses 2019-2025 | BGLC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

BioNexus Gene Lab operating expenses from 2019 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

BioNexus Gene Lab Operating Expenses 2019-2025 | BGLC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

BioNexus Gene Lab operating expenses from 2019 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$147.1B
CVS Health (CVS)	$83B
Elevance Health (ELV)	$78.1B
Cencora (COR)	$57.6B
DiDi Global (DIDIY)	$23.8B
Natera (NTRA)	$22.3B
Labcorp Holdings (LH)	$21.2B
BioMerieux (BMXMF)	$16.9B
EUROFINS SCIENT (ERFSF)	$13.8B
Solventum (SOLV)	$13.1B
CochLear (CHEOY)	$12.8B
ICON (ICLR)	$12.3B
Revvity (RVTY)	$12.1B
Viatris (VTRS)	$10.9B
Medpace Holdings (MEDP)	$9.4B
Avantor (AVTR)	$9.3B
Sonic Healthcare (SKHHY)	$8.6B
HealthEquity (HQY)	$8.4B
Charles River Laboratories (CRL)	$8B
Caris Life Sciences,�Inc (CAI)	$6.8B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$5B
BrightSpring Health Services (BTSG)	$3.7B
Sotera Health (SHC)	$3.4B
Surgery Partners (SGRY)	$2.9B
Alignment Healthcare (ALHC)	$2.6B
Concentras Parent (CON)	$2.6B
Organon (OGN)	$2.6B
GeneDx Holdings (WGS)	$2.5B
Ardent Health (ARDT)	$2B